Research output per year
Research output per year
Personal profile
Research
As a PhD student, I conduct research in epidemiology, health economics and chronic kidney disease. In my work, I am responsible for conducting statistical analyses, writing scientific articles and teaching. I have a degree health economics (Master of Science).
Job responsibilities
My primary area of responsibility is researching and writing my PhD including teaching, statistics and learning new methods for research. I also contribute to CONNECT; the Central Denmark Region's and Aarhus University's common data support unit.
Areas of expertise
- Health economics
- Real-world evidence
- Health policy
Fingerprint
Dive into the research topics where Matilde Slot is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study
Slot, M., Rasmussen, T. B., Nørgaard, M., Larsen, C. S. & Ehlers, L. H., Nov 2024, In: PharmacoEconomics - Open. 8, 6, p. 847-856 10 p.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access1 Citation (Scopus) -
Cost-effectiveness of targeted treatment vs chemoimmunotherapy in treatment-naive unfit CLL without TP53 aberrations
Slot, M., Niemann, C. U., Ehlers, L. H. & Rotbain, E. C., Aug 2023, In: Blood Advances. 7, 15, p. 4186-4196 11 p.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access4 Citations (Scopus) -
Cost-Utility of Venetoclax Plus Obinutuzumab for Treatment-Naïve Patients with Chronic Lymphocytic Leukemia without Del17p/TP53-Mutation Compared to Chlorambucil Plus Obinutuzumab
Slot, M., 2022, In: Blood.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Conference abstract in journal › Research › peer-review
Open Access
-
European Hematology Association (EHA) 2023 (Event)
Slot, M. (Reviewer)
2022Activity: Publication peer-review and editorial work types › Peer review of manuscripts › Communication
-
Oral abstract presentation
Slot, M. (Invited speaker)
2022Activity: Presentations, memberships, employment, ownership and other activities › Lecture and oral contribution
Press/Media
-
Ny, målrettet behandling mod CLL betaler sig både, når det gælder økonomi og livskvalitet sammenlignet med standardbehandling med kemoterapi og antistoffer
01/04/2023
1 item of Media coverage
Press/Media: Press / Media
-
Dyr og avansert kreftpille er mer kostnadseffektiv enn billig kjemoterapi
13/12/2022
1 item of Media coverage
Press/Media: Press / Media
-
Venetoclax bør foretrækkes over klorambucil til bestemt CLL-patientgruppe
13/12/2022
1 Media contribution
Press/Media: Press / Media
-
Venetoclax plus obinutuzumab is cost-effective for treatment of CLL without del17p/TP53-mutation
12/12/2022
1 Media contribution
Press/Media: Press / Media